Market Research Logo

Basilea Pharmaceutica AG - Product Pipeline Review - 2015

Basilea Pharmaceutica AG - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Basilea Pharmaceutica AG - Product Pipeline Review - 2015’, provides an overview of the Basilea Pharmaceutica AG’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Basilea Pharmaceutica AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Basilea Pharmaceutica AG including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Basilea Pharmaceutica AG’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Basilea Pharmaceutica AG’s pipeline products
Reasons to buy
  • Evaluate Basilea Pharmaceutica AG’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Basilea Pharmaceutica AG in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Basilea Pharmaceutica AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Basilea Pharmaceutica AG and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Basilea Pharmaceutica AG
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Basilea Pharmaceutica AG and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Basilea Pharmaceutica AG Snapshot
Basilea Pharmaceutica AG Overview
Key Information
Key Facts
Basilea Pharmaceutica AG - Research and Development Overview
Key Therapeutic Areas
Basilea Pharmaceutica AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Basilea Pharmaceutica AG - Pipeline Products Glance
Basilea Pharmaceutica AG - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Filing rejected/Withdrawn Products/Combination Treatment Modalities
Basilea Pharmaceutica AG - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Basilea Pharmaceutica AG - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Basilea Pharmaceutica AG - Drug Profiles
isavuconazonium sulfate
Product Description
Mechanism of Action
R&D Progress
ceftobiprole medocaril
Product Description
Mechanism of Action
R&D Progress
BAL-101553
Product Description
Mechanism of Action
R&D Progress
BAL-30072
Product Description
Mechanism of Action
R&D Progress
BAL-3833
Product Description
Mechanism of Action
R&D Progress
CCT-196969
Product Description
Mechanism of Action
R&D Progress
CCT-241161
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Inflammatory Diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Hematological and Solid Cancers
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Beta-Lactamase for Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Basilea Pharmaceutica AG - Pipeline Analysis
Basilea Pharmaceutica AG - Pipeline Products by Target
Basilea Pharmaceutica AG - Pipeline Products by Route of Administration
Basilea Pharmaceutica AG - Pipeline Products by Molecule Type
Basilea Pharmaceutica AG - Pipeline Products by Mechanism of Action
Basilea Pharmaceutica AG - Recent Pipeline Updates
Basilea Pharmaceutica AG - Dormant Projects
Basilea Pharmaceutica AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
BAL-2299
Basilea Pharmaceutica AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Basilea Pharmaceutica AG, Key Information
Basilea Pharmaceutica AG, Key Facts
Basilea Pharmaceutica AG - Pipeline by Indication, 2015
Basilea Pharmaceutica AG - Pipeline by Stage of Development, 2015
Basilea Pharmaceutica AG - Monotherapy Products in Pipeline, 2015
Basilea Pharmaceutica AG - Out-Licensed Products in Pipeline, 2015
Basilea Pharmaceutica AG - Out-Licensed Products/ Combination Treatment Modalities, 2015
Basilea Pharmaceutica AG - Pre-Registration, 2015
Basilea Pharmaceutica AG - Filing rejected/Withdrawn, 2015
Basilea Pharmaceutica AG - Phase II, 2015
Basilea Pharmaceutica AG - Phase I, 2015
Basilea Pharmaceutica AG - Preclinical, 2015
Basilea Pharmaceutica AG - Discovery, 2015
Basilea Pharmaceutica AG - Pipeline by Target, 2015
Basilea Pharmaceutica AG - Pipeline by Route of Administration, 2015
Basilea Pharmaceutica AG - Pipeline by Molecule Type, 2015
Basilea Pharmaceutica AG - Pipeline Products by Mechanism of Action, 2015
Basilea Pharmaceutica AG - Recent Pipeline Updates, 2015
Basilea Pharmaceutica AG - Dormant Developmental Projects,2015
Basilea Pharmaceutica AG - Discontinued Pipeline Products, 2015
Basilea Pharmaceutica AG, Subsidiaries
List of Figures
Basilea Pharmaceutica AG - Pipeline by Top 10 Indication, 2015
Basilea Pharmaceutica AG - Pipeline by Stage of Development, 2015
Basilea Pharmaceutica AG - Monotherapy Products in Pipeline, 2015
Basilea Pharmaceutica AG - Out-Licensed Products in Pipeline, 2015
Basilea Pharmaceutica AG - Pipeline by Top 10 Target, 2015
Basilea Pharmaceutica AG - Pipeline by Top 10 Route of Administration, 2015
Basilea Pharmaceutica AG - Pipeline by Top 10 Molecule Type, 2015
Basilea Pharmaceutica AG - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report